牛牛AI助理已提取核心訊息
Intelligent Bio Solutions Inc. has formally requested the U.S. Securities and Exchange Commission (SEC) to accelerate the effective date of its Registration Statement on Form S-3. The company, headquartered in New York and incorporated in Delaware, submitted the request via a letter dated March 13, 2024, addressed to the SEC's Division of Corporate Finance. Intelligent Bio Solutions Inc. seeks to have the Registration Statement become effective at 4:30 P.M. Eastern Time on March 15, 2024. The request was signed by Spiro Sakiris, the Chief Financial Officer of Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc. has formally requested the U.S. Securities and Exchange Commission (SEC) to accelerate the effective date of its Registration Statement on Form S-3. The company, headquartered in New York and incorporated in Delaware, submitted the request via a letter dated March 13, 2024, addressed to the SEC's Division of Corporate Finance. Intelligent Bio Solutions Inc. seeks to have the Registration Statement become effective at 4:30 P.M. Eastern Time on March 15, 2024. The request was signed by Spiro Sakiris, the Chief Financial Officer of Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc.已正式要求美國證券交易委員會（SEC）加快其S-3表格註冊聲明的生效日期。該公司總部位於紐約，在特拉華州註冊成立，通過2024年3月13日致美國證券交易委員會企業融資部的信函提交了申請。Intelligent Bio Solutions Inc.希望註冊聲明於美國東部時間2024年3月15日下午4點30分生效。該請求由智能生物解決方案公司首席財務官斯皮羅·薩基里斯簽署。
Intelligent Bio Solutions Inc.已正式要求美國證券交易委員會（SEC）加快其S-3表格註冊聲明的生效日期。該公司總部位於紐約，在特拉華州註冊成立，通過2024年3月13日致美國證券交易委員會企業融資部的信函提交了申請。Intelligent Bio Solutions Inc.希望註冊聲明於美國東部時間2024年3月15日下午4點30分生效。該請求由智能生物解決方案公司首席財務官斯皮羅·薩基里斯簽署。
有用
沒用
該公告為獨立文件：